Dr. Jens Teichmann has been serving as COO of Morphochem AG, a 100% subsidiary of Biovertis AG, Vienna, since April 2017. He is also COO of Biovertis since July 2017.
He joined Morphochem on the MCB3837 Project in 2009 as Chemistry, Manufacturing and Control (CMC) Expert and Project Manager.
Jens Teichmann is Managing Director at TeProPharm Consult GmbH since 2009. Before he served as Head of Customer Service & Project Management with power of procuration at Haupt Pharma Wolfratshausen GmbH and as Head of Business Development and Contract Manufacturing at Baxter Oncology GmbH, Bielefeld. At ChemCon GmbH he worked as R&D scientist for API syntheses and as Marketing & Sales Manager.
Dr. Jens Teichmann received a diploma degree in Chemistry and a Doctorate in Pharmaceutical Chemistry from the University of Heidelberg, Germany.